Belarus' cardiology service is consistently expanding its capabilities: the volume of high-tech interventions is growing, the role of regional centres is expanding, and modern techniques – developed ...

Background Preprocedural risk prediction of 30-day all-cause mortality after percutaneous coronary intervention (PCI) aids in clinical decision-making and benchmarking hospital performance. This study ...

A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress—heart muscle damage without symptoms of ...

Bloodstream infections (BSI) can turn deadly fast, particularly for patients with weakened immune systems. A new study from Houston Methodist Research Institute finds that artificial intelligence can ...

A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress — heart muscle damage without symptoms ...

Heart attacks are no longer just a threat in later life, and new data show younger adults, especially women, are increasingly ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

A new study finds that heart attack deaths in U.S. hospitals are rising in people aged 54 and below, signaling a shift in ...

In-hospital mortality was significantly higher for younger women vs. younger men after a first heart attack, with women ...

People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and common antihistamines, are at higher risk of developing cardiovascular disease.

Immunocompromised status remains a significant risk factor for in-hospital mortality in COVID-19, particularly among patients with pneumonia.

• The incidence of no-reflow was significantly higher in the thrombectomy group (1.4% vs 0.2%), which researchers attributed ...